FXYD6 and cholangiocarcinoma: Phosphohippolin (PPH, FXYD6 gene), a transmembrane protein that functions as an ion channel and affects the activity of Na+/K+-ATPase, has been found upregulated in CCA compared with normal bile duct tissue, and has been proposed as a new potential biomarker and therapeutic target for CCA [23] (Figure 1).